WYNNEFIELD CAPITAL INC

Holdings History for LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR)

Symbol: LFCR on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	22%	0%	$38,472,306	4,703,216	0		$8.18	Q4 2025
30 Sep 2025	21%	0%	$34,615,669	4,703,216	0		$7.36	Q3 2025
30 Jun 2025	23%	0%	$38,190,113	4,703,216	0		$8.12	Q2 2025
31 Mar 2025	21%	0%	$33,110,640	4,703,216	0		$7.04	Q1 2025
31 Dec 2024	16%	-0.73%	$34,944,894	4,703,216	-215,763	-4.4%	$7.43	Q4 2024
30 Sep 2024	11%	0%	$24,250,566	4,918,979	0		$4.93	Q3 2024
30 Jun 2024	11%	-0.01%	$25,234,362	4,918,979	-4,566	-0.09%	$5.13	Q2 2024
31 Mar 2024	10%	0%	$26,144,024	4,923,545	0		$5.31	Q1 2024
31 Dec 2023	12%	0%	$30,476,744	4,923,545	0		$6.19	Q4 2023
30 Sep 2023	17%	0%	$37,148,147	4,923,545	0		$7.54	Q3 2023
30 Jun 2023	24%	0%	$47,610,680	4,923,545	0		$9.67	Q2 2023
31 Mar 2023	12%	+1.1%	$18,586,382	4,923,545	+461,035	+10%	$3.77	Q1 2023
31 Dec 2022	17%	+3.5%	$28,917,065	4,462,510	+929,223	+26%	$6.48	Q4 2022
30 Sep 2022	17%	0%	$31,411,000	3,533,287	0		$8.89	Q3 2022
30 Jun 2022	18%	0%	$35,227,000	3,533,287	0		$9.97	Q2 2022
31 Mar 2022	16%	+1.7%	$40,915,000	3,533,287	+387,400	+12%	$11.58	Q1 2022
31 Dec 2021	12%	0%	$34,919,000	3,145,887	0		$11.10	Q4 2021
30 Sep 2021	16%	0%	$29,005,000	3,145,887	0		$9.22	Q3 2021
30 Jun 2021	16%	+1.2%	$35,391,000	3,145,887	+240,587	+8.3%	$11.25	Q2 2021
31 Mar 2021	15%	+0.11%	$30,651,000	2,905,300	+20,000	+0.69%	$10.55	Q1 2021
31 Dec 2020	16%	+0.05%	$31,306,000	2,885,300	+10,000	+0.35%	$10.85	Q4 2020
30 Sep 2020	17%	0%	$27,948,000	2,875,300	0		$9.72	Q3 2020
30 Jun 2020	17%	+0.03%	$22,887,000	2,875,300	+5,000	+0.17%	$7.96	Q2 2020
31 Mar 2020	24%	0%	$24,943,000	2,870,300	0		$8.69	Q1 2020
31 Dec 2019	22%	0%	$32,463,000	2,870,300	0		$11.31	Q4 2019
30 Sep 2019	17%	+0.43%	$31,200,000	2,870,300	+75,000	+2.7%	$10.87	Q3 2019
30 Jun 2019	13%	+0.29%	$26,192,000	2,795,300	+60,000	+2.2%	$9.37	Q2 2019
31 Mar 2019	16%	+0.31%	$33,590,000	2,735,300	+52,900	+2%	$12.28	Q1 2019
31 Dec 2018	16%	0%	$31,759,000	2,682,400	0		$11.84	Q4 2018
30 Sep 2018	16%	0%	$38,627,000	2,682,400	0		$14.40	Q3 2018
30 Jun 2018	15%	0%	$39,968,000	2,682,400	0		$14.90	Q2 2018
31 Mar 2018	12%	0%	$35,005,000	2,682,400	0		$13.05	Q1 2018
31 Dec 2017	12%	0%	$33,798,000	2,682,400	0		$12.60	Q4 2017
30 Sep 2017	12%	0%	$34,737,000	2,682,400	0		$12.95	Q3 2017
30 Jun 2017	13%	0%	$39,833,000	2,682,400	0		$14.85	Q2 2017
31 Mar 2017	12%	0%	$32,188,000	2,682,400	0		$12.00	Q1 2017
31 Dec 2016	13%	0%	$37,016,000	2,682,400	0		$13.80	Q4 2016
30 Sep 2016	12%	0%	$35,970,000	2,682,400	0		$13.41	Q3 2016
30 Jun 2016	10%	0%	$28,863,000	2,682,400	0		$10.76	Q2 2016
31 Mar 2016	11%	0%	$28,165,000	2,682,400	0		$10.50	Q1 2016
31 Dec 2015	11%	+0.07%	$31,732,000	2,682,400	+17,400	+0.65%	$11.83	Q4 2015
30 Sep 2015	12%	+0.07%	$31,101,000	2,665,000	+15,000	+0.57%	$11.67	Q3 2015
30 Jun 2015	15%	0%	$38,239,000	2,650,000	0		$14.43	Q2 2015
31 Mar 2015	16%	0%	$36,967,000	2,650,000	0		$13.95	Q1 2015
31 Dec 2014	15%	+0.12%	$36,596,000	2,650,000	+20,000	+0.76%	$13.81	Q4 2014
30 Sep 2014	14%	+4.9%	$30,039,000	2,630,000	+915,600	+53%	$11.42	Q3 2014
30 Jun 2014	9.9%	0%	$21,412,000	1,714,400	0		$12.49	Q2 2014
31 Mar 2014	9.3%	+0.42%	$19,132,000	1,714,400	+76,414	+4.7%	$11.16	Q1 2014
31 Dec 2013	8.6%	0%	$19,141,000	1,637,986	0		$11.69	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.